What I don't understand is, why will take 6 more weeks for the FDA, (Forever Dragging Ass) to review Bioelectronics 510K subsmission. They have had 9 years to analyze, roadblock and delay the “ActiPatch” approval. What's left to review?
(0)
(0)
BioElectronics Corporation (BIEL) Stock Research Links
